Social media is accelerating the spread of misleading health information, and public health experts say rebuilding trust will ...

The FDA has granted full approval to Kura Oncology and Kyowa Kirin’s Komzifti (ziftomenib), marking the first FDA-approved once-daily, oral menin inhibitor for adults with relapsed or refractory (R/R) ...

Q3 2025 Earnings Call November 14, 2025 4:00 AM ESTCompany ParticipantsJarle Dragvik - Chief Executive OfficerMartin Holtet ...

Runners focus on nutrition and recovery strategies to optimize training, but they often overlook one of the most important ...

A new study found that having gray hair may be a sign your body is working to protect you from melanoma, the deadliest form ...

Santam has strengthened its executive leadership with the appointment of Philile Mkhize as Group chief operating officer, effective Monday, 1 December 2025.Mkhize brings 25 years of executive ...

Jensen underscored how India’s grassroots adoption of AI is outpacing most global markets. “The adoption of AI by small ...

In May 2024, ILRI and partners shared news of the first drone flights over rangeland animals in Africa to test whether this ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

Spine conversations evolve digital as surgeons address patient misinformation from online sources to improve treatment decisions.

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

AI enhances breast cancer care by improving mammography accuracy, reducing false negatives, and aiding in clinical trial enrollment and design. AI-driven digital patient profiling reduces placebo use ...